Revenue and net income declined year-over-year, with H1 2025 sales at KRW 170.9 billion and net income at KRW 2.2 billion. The company maintains a strong balance sheet, continues to invest in EMS capabilities, and holds significant treasury shares.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.